4.6 Editorial Material

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Increased type 2 inflammation post rhinovirus infection in patients with moderate asthma

Thomas Southworth et al.

CYTOKINE (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Editorial Material Critical Care Medicine

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?

David M. G. Halpin et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Respiratory System

Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD

Marco Cantoli et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Article Respiratory System

Viral infections and asthma: an inflammatory interface?

Brian G. G. Oliver et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

Article Respiratory System

Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses

Yury A. Bochkov et al.

RESPIRATORY RESEARCH (2013)

Article Allergy

Nasal cytokine responses to natural colds in asthmatic children

T. C. Lewis et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2012)

Article Multidisciplinary Sciences

Budesonide and Formoterol Reduce Early Innate Anti-Viral Immune Responses In Vitro

Janet M. Davies et al.

PLOS ONE (2011)

Review Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

PLOS MEDICINE (2009)

Review Medicine, General & Internal

SARS: Systematic review of treatment effects

Lauren J. Stockman et al.

PLOS MEDICINE (2006)